英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字,中文词皆可:

wanderingly    


安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • MediciNova, Inc. | Patients voice. Our choice.
    Patients voice Our choice MediciNova is a biopharmaceutical company that is developing novel therapeutics with a primary focus on neurology, respiratory, and liver diseases with unmet medical needs
  • Management Team | MediciNova, Inc.
    Prior to joining MediciNova, Dr Matsuda was assistant professor, University of Southern California, Keck School of Medicine after an appointment at the Children’s Hospital Los Angeles Dr Matsuda commenced her residency in internal medicine pediatrics at Michigan State University and completed a pediatric residency at Loma Linda University
  • Ongoing Clinical Trial | MediciNova, Inc.
    Copyright © 2021 MEDICINOVA, Inc All Rights Reserved | Terms of Use | Privacy Policy
  • Corporate Presentation and Equity Research Analyst Reports - MediciNova
    Corporate Presentation amp; Research ReportsMN-166 (ibudilast) PresentationsMN-001 (tipelukast) PresentationsCorporate Pres
  • About Company | MediciNova, Inc.
    MediciNova, Inc is a publicly-traded biopharmaceutical company focused on acquiring and developing novel therapeutics for the treatment of diseases with unmet medical needs and a specific focus on the U S market Through strategic alliances primarily with Japanese pharmaceutical companies, MediciNova holds rights to a diversified portfolio of clinical and preclinical product candidates, each
  • Contact Us | MediciNova, Inc.
    Address4275 Executive Square, Suite 300 La Jolla, CA 92037 USAPhone (858) 373-1500Fax (858) 404-0048Emailinfo@medicinova c
  • History | MediciNova, Inc.
    2000Sep Founded in San Diego, California, USADec First Series A Preferred Stock Issued to Tanabe Seiyaku Co , Ltd 2001Au
  • Terms Of Use - MediciNova, Inc.
    MediciNova specifically disclaims any liability, whether based in contract, tort, strict liability or otherwise, for any direct, indirect, incidental, consequential or special damages arising out of or in any way connected with access to, use of or inability to use this website, or any errors or omissions in the content thereof, even if
  • MediciNova Corporate Presentation
    These forward-looking statements include statements regarding MediciNova’s clinical trials supporting the safety and efficacy of its product candidates and the potential novelty of such product candidates as treatments for disease, plans and objectives for clinical trials and product development, strategies, future performance, expectations
  • MediciNova to Participate at the 38th Annual ROTH Conference
    MediciNova, Inc is a clinical-stage biopharmaceutical company developing a broad late-stage pipeline of novel small molecule therapies for inflammatory, fibrotic, and neurodegenerative diseases





中文字典-英文字典  2005-2009